Adial Pharmaceuticals Inc (ADIL)


Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Adial Pharmaceuticals Inc chart...

About the Company

adial pharmaceuticals is dedicated to personalized treatment for drug abuse and addiction. while our pipeline includes drug candidates for the treatment of opiate and amphetamine use, our two lead drug candidates are for the treatment of alcohol abuse. adial leverages its extensive knowledge of pharmacology and pharmacogenomics to change the paradigm of drug abuse treatment.

Exchange

NASDAQ

Website

adialpharma.com

$M

Total Revenue

6

Employees

$2M

Market Capitalization

-1.85

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ADIL News

ADIL Adial Pharmaceuticals, Inc.

3d ago, source: Seeking Alpha

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead ...

Why Adial Pharmaceuticals Stock Is Blasting Off

19d ago, source: Hosted on MSN

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares are trading higher Wednesday after the company announced that it was awarded a new patent covering AD04 for the potential treatment of opioid use ...

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

17d ago, source: Business Insider

CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage ...

EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Lead Product For Alcohol Use Disorder

19d ago, source: Hosted on MSN

W ednesday, Adial Pharmaceuticals Inc (NASDAQ:ADIL) announced patent number 11,905,562 was issued on February 20, 2024, by the United States Patent and Trademark Office. The patent covers the ...

Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

19d ago, source: Finanznachrichten

CHARLOTTESVILLE, Va., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) ("Adial" or the "Company"), a clinical-stage ...

Adial Pharmaceuticals Inc (ADIL)

1d ago, source: Investing

Adial Pharma announced... Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) today provided a business update and reported its financial results for the second quarter of 2022.William Stilley ...

Why Adial Pharmaceuticals Stock Is Blasting Off

19d ago, source: Benzinga.com

Adial shares are trading higher Wednesday after the company announced that it was awarded a new patent. Benzinga broke the news first Wednesday morning with an exclusive report before the opening ...

EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Lead Product For Alcohol Use Disorder

20d ago, source: Benzinga.com

Adial Pharmaceuticals says the new patent strengthens its patent portfolio and covers meaningful aspects of lead asset AD04. Adial says AD04 has significant potential to treat opioid use disorder ...

Adial Pharmaceuticals Inc ADIL

26d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Adial Pharmaceuticals Inc (ADIL)

20d ago, source: Investing

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...